Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS

Clinical trial NCT05633407 · COMPLETED

Trial details

NCT number: NCT05633407
Sponsor: argenx
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postural Orthostatic Tachycardia Syndrome

Start date: 2022-09-23
Primary completion: 2024-04-18
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.